»
Novel Psychoactive Substances
 
 

Novel Psychoactive Substances, 1st Edition

Classification, Pharmacology and Toxicology

 
Novel Psychoactive Substances, 1st Edition,Paul Dargan,David Wood,ISBN9780124158160
 
 
Up to
25%
off
 

Dargan   &   Wood   

Academic Press

9780124158160

9780124159112

440

235 X 191

An authoritative reference containing the classification, detection, supply and pharmacology of novel psychoactive substances and key information on the patterns of acute and chronic harm associated with their use

Print Book + eBook

USD 119.94
USD 199.90

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 74.96
USD 99.95

eBook
eBook Overview

VST (VitalSource Bookshelf) format

DRM-free included formats : EPUB, Mobi (for Kindle), PDF

USD 74.96
USD 99.95
Add to Cart
 
 

Key Features

  • Includes chapters written by international experts in the field.
  • Provides a comprehensive look at the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance.
  • Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies.
  • Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene including mephedrone and the synthetic cannabinoid receptors in ‘spice’ / ‘K2’.

Description

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology provides readers with background on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." This book also covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance followed by a discussion of the acute and chronic harm or toxicity associated with the substance. Written by international experts in the field, this multi-authored book is a valuable reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.

Readership

Research scientists and academics in pharmacology and toxicology, biochemists and healthcare professionals, including physicians, nurses and paramedics, law enforcement and legislative authorities.

Paul Dargan

Drs. Dargan and Wood are both expert advisors to the UK Government (Advisory Council on the Misuse of Drugs, ACMD), UK Law Enforcement Services (Association of Chief Police Officers and Serious Organised Crime Agencies) and the European Union (European Monitoring Centre for Drugs and Drug Addiction, EMCDDA). They run a clinical service and have a clinical and research interest in novel psychoactive substances. They publish widely in this field and have both been invited to give keynote lectures at International meetings on this topic.

Affiliations and Expertise

Consultant Physician and Clinical Toxicologist, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK

David Wood

Affiliations and Expertise

Consultant Physician and Clinical Toxicologist, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK

Novel Psychoactive Substances, 1st Edition

Forewords

List of Contributors

Section 1: Background

Chapter 1. Legal Classification of Novel Psychoactive Substances: An International Comparison

Introduction

Traditional Control Mechanisms

Recent Developments

References

Chapter 2. Monitoring Novel Psychoactive Substances: A Global Perspective

Introduction

Definitions

The Identification, Risk Assessment and Monitoring of Novel Psychoactive Substances

The EU Ews Information Exchange

International, Regional and National Drug Monitoring Systems

Sources for Detecting and Monitoring Novel Psychoactive Substances

Conclusions

References

Chapter 3. Availability and Supply of Novel Psychoactive Substances

Background

Novel Psychoactive Substance Market

NPS Origins and Market Entry

NPS Market Structure

Products

Conclusions

References

Chapter 4. Epidemiology of Use of Novel Psychoactive Substances

Introduction

General Population Surveys

Summary and Conclusions

References

Chapter 5. Social Issues in the Use of Novel Psychoactive Substances: Differentiated Demand and Ideological Supply

Introduction

Availability

Prevalence in Context: Differentiated Demand in Different Leisure Venues

Understanding Motivations: The Displacement Question

Exploring Social Harms: Legislative Control and the Supply of NPS

Policy Options in a Changing World

The NPS Debate: Historical Stagnation and Vested Interests (A UK Perspective)

Conclusion

References

Section 2: Analytical Techniques

Chapter 6. Analytical Techniques for the Detection of Novel Psychoactive Substances and Their Metabolites

Introduction

Analytical Methods Covering Several Classes of Novel Psychoactive Substances

Methods for Screening and/or Quantification of Novel Psychoactive Substances from Specific Drug Classes

Recommendations for Setting up Analytical Methods for Analysis of Novel Psychoactive Substances

References

Section 3: Individual Novel Psychoactive Substances

Chapter 7. Synthetic Amphetamine Derivatives

Pharmacology

Monomethoxy Derivatives

Dimethoxy Derivatives

Trimethoxy Derivatives

Thiol-Derivatives

4-Fluoroamphetamine

Monomethyl Derivatives

Summary

References

Chapter 8. 1-Benzylpiperazine and other Piperazine-based Derivatives

Introduction

Pharmacology

Toxicology

Treatment

Chronic Toxicity

Dependence and Abuse Potential

Conclusion

Acknowledgment

References

Chapter 9. Mephedrone

Introduction

Pharmacology

Prevalence of Use

Acute Toxicity

Mephedrone-Related Deaths

Chronic Toxicity

Dependence and Abuse Potential

References

Chapter 10. Pipradrol and Pipradrol Derivatives

Pharmacology

Prevalence of Use

Acute Toxicity

Chronic Toxicity

Dependence and Abuse Potential

Conclusions

References

Chapter 11. Aminoindane Analogues

Introduction

Pharmacology

Prevalence of Use

Regulation of the Aminoindanes

Acute and Chronic Toxicity

Dependence and Abuse Potential

Conclusions

References

Chapter 12. Ketamine

Introduction

Pharmacology and Animal Models of Ketamine Toxicity

Physical and Chemical Description

Acute Toxicity

Chronic Toxicity

Dependence and Abuse Liability

References

Chapter 13. Synthetic Cannabinoid Receptor Agonists

Introduction

Pharmacology

Prevalence of Use

Acute Toxicity

Chronic Toxicity

Dependence and Abuse Potential

Forensic Relevance

Conclusions

References

Chapter 14. Natural Product (Fungal and Herbal) Novel Psychoactive Substances

Introduction

Fungal NPS

Conclusions

Acknowledgments

References

Chapter 15. Tryptamines

Tryptamines

Pharmacology

Prevalence of Use

Acute Toxicity

Chronic Toxicity

Dependence and Abuse Potential

Conclusions

References

Chapter 16. Benzofurans and Benzodifurans

Benzofurans

Pharmacology

Prevalence of Use

Acute Toxicity

Chronic Toxicity

Dependence and Abuse Potential

References

Chapter 17. Miscellaneous Compounds

Methoxetamine

Dimethylamylamine (DMAA)

Synthetic Cocaines

References

Index

Quotes and reviews

"…this book provides up to date information on the classification, pharmacology, and toxicology of novel psychoactive substances often referred to as "legal highs" or "bath salts." The recreational abuse of these substances, driven by the twin engines of globalization and technology, has markedly expanded during the past decade…I highly recommend this book to anyone who is involved in investigating, treating, monitoring, or regulating the abuse of novel psychoactive substances."  Rating: 4 Stars--Doody.com, January 17, 2014
"The background, analytical techniques, and individual novel psychoactive substances are discussed by researchers in pharmaceuticals, law, public health, and various medical specialties. The topics include a global perspective on monitoring them, analytical techniques for detecting them and their metabolites, synthetic amphetamine derivatives, aminoindane analogues, ketamine, synthetic cannabinoid receptor agonists, natural fungal and herbal substances, and benzofurans and benzodifurans."--Reference & Research Book News, December 2013
"This reference book comprehensively collates a vast range of facts and details about the recently much debated topic of novel psychoactive substances, including the much talked about ‘legal highs’…This book would be a useful reference source for those with a keen interest in novel psychoactive substances internationally, and appeal to those working in this specialist area whether in the field of research or academics, or clinically."--PJonline.com, December 4, 2013

 
 
Free Shipping
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ

Contact Us